Post-sacrifice tumor samples confirmed induction of HuD shRNA (by upregulation of GFP as a built-in marker for doxy induction); the levels of proliferation marker Ki67 were also reduced in the induced samples; staining with GL2, a neuroblastoma marker [32], allowed identifying the tumor cells from non-tumor ones (Fig. 8G and H). The gene discussed is ELAVL4; the disease is neoplasm.